Trial Profile

A Phase 1b/2 Study to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

Status: Not yet recruiting

Phase of Trial: Phase I/II

Latest Information Update: 10 Feb 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs NB 4746 (Primary)
Indications Amyotrophic lateral sclerosis; Neurological disorders
Focus Adverse reactions
Sponsors Nura Bio

Most Recent Events

27 Jan 2026 Status changed from planning to not yet recruiting.
19 Sep 2024 According to Nura Bio media release, company plans to initiate a Phase 1b/2 trial in a patient population in 2025.
19 Sep 2024 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com